HIGHLIGHTS
- who: December and colleagues from the Xiyuan Hospital, China Fudan University, China have published the research work: The ef cacy and safety of Yupingfeng Powder with variation in the treatment of allergic rhinitis: Study protocol for a randomized, double-blind, placebo-controlled trial, in the Journal: Gut microbiota
- what: In this project, the authors designed a double-blind, randomized, placebo controlled clinical trial to assess the efficacy of Yupingfeng Powder with variation for AR patients with TCM syndrome of qi deficiency of lung and spleen, and to explore the molecular mechanism of Yupingfeng Powder in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.